AI assistant
Sending…
BAXTER INTERNATIONAL INC — Director's Dealing 2021
Jun 24, 2021
30537_dirs_2021-06-23_2bb0dee3-4796-4425-813c-fbc594d54eda.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Miromatrix Medical Inc. (MIRO)
CIK: 0001527096
Period of Report: 2021-06-23
Reporting Person: BAXTER INTERNATIONAL INC (10% Owner)
Reporting Person: BAXTER HEALTHCARE CORP (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series C Convertible Preferred Stock | $ | Common Stock (2343750) | Indirect |
Footnotes
F1: The Series C Convertible Preferred Stock is convertible into the number of shares of the Issuer's common stock shown in column 3 and have no expiration date. The Series C Convertible Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
F2: The reported securities are owned directly by Baxter Healthcare Corporation, a wholly owned subsidiary of Baxter International Inc.
More from BAXTER INTERNATIONAL INC
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
May 6
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Major Shareholding Notification
2026
Apr 27
Major Shareholding Notification
2026
Apr 21
Major Shareholding Notification
2026
Mar 26